Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Revenue

In the year 2024, Blueprint Medicines had annual revenue of $508.82M with 104.04% growth. Blueprint Medicines had revenue of $146.37M in the quarter ending December 31, 2024, with 103.41% growth.

• Revenue (ttm): $508.82M
• Revenue Growth: +104.04%
• P/S Ratio: 10.93
• Revenue / Employee: $784,012
• Employees: 649
• Market Cap: 5.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	508.82M	259.44M	104.04%
Dec 31, 2023	249.38M	45.34M	22.22%
Dec 31, 2022	204.04M	23.96M	13.30%
Dec 31, 2021	180.08M	-613.66M	-77.31%
Dec 31, 2020	793.74M	727.22M	1,093.37%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.